Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Screening for Immunodeficiencies in Children With Invasive Pneumococcal Disease: Six-year Experience From a UK Children's Hospital

Bijker EM. et al, (2022), Pediatric Infectious Disease Journal, 41, 575 - 578

Year-to-year variation in attack rates could result in underpowered respiratory syncytial virus vaccine efficacy trials

Billard MN. et al, (2022), Journal of Clinical Epidemiology, 147, 11 - 20

Monogenic inflammatory bowel disease-genetic variants, functional mechanisms and personalised medicine in clinical practice.

Azabdaftari A. et al, (2022), Hum Genet

Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease.

Serra EG. et al, (2022), Nat Commun, 13

Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial.

Strauss KA. et al, (2022), Nature medicine

Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial.

Strauss KA. et al, (2022), Nature medicine

Processing single-cell RNA-seq datasets using SingCellaR.

Wang G. et al, (2022), STAR Protoc, 3

Inclusion of a dual signal sequence enhances the immunogenicity of a novel viral vectored vaccine against the capsular group B meningococcus.

Sheerin D. et al, (2022), Cell Biosci, 12

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.

Li G. et al, (2022), Lancet, 399, 2212 - 2225

Immunogenicity of a single 4CMenB vaccine booster in adolescents 11 years after childhood immunisation.

Rollier CS. et al, (2022), Vaccine

Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial.

Shaw RH. et al, (2022), Lancet Respir Med

Financial cost and quality of life of patients with spinal muscular atrophy identified by symptoms or newborn screening.

Dangouloff T. et al, (2022), Dev Med Child Neurol

Continuous Indexing of Fibrosis (CIF): Improving the Assessment and Classification of MPN Patients

Ryou H. et al, (2022)

Accelerated epigenetic aging in newborns with Down syndrome

Xu K. et al, (2022), Aging Cell

In utero origin of myelofibrosis presenting in adult monozygotic twins

Sousos N. et al, (2022), Nature Medicine

PAF1 and FACT cooperate with MLL-AF4 to drive enhancer activity in leukemia

Crump NT. et al, (2022)

Viral vector vaccines.

McCann N. et al, (2022), Curr Opin Immunol, 77

Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trial

MAIDEN M. et al, (2022), Vaccine

Epigenome-Wide Association Study of Acute Lymphoblastic Leukemia in Children with Down Syndrome.

Li S. et al, (2022), Blood Adv

Future reporting of vaccine uptake needs to include any change in ethnic or socioeconomic disparities.

Hoang U. et al, (2022), BMJ, 377

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?